HSCS: Heart Test Laboratories, Inc. Price to Sales

Brandmark of Heart Test Labs (HSCS)

Heart Test Laboratories (HSCS) integrates ESG principles into AI-driven ECG diagnostics, optimizing device energy consumption and ensuring patient data protection. This price-to-sales chart clearly illustrates the valuation trend, where the metric settled at 774.80. Revenue is driven by the sale of cardiology smart systems and cloud software. Crisis resilience is underpinned by stable demand for innovation and the successful commercialization of proprietary developments.

Price-to-Revenue Ratio: heartsciences.com (HSCS) for 04/28/2023 - 07/24/2026

Heart Test Laboratories Inc. (HSCS) - metric breakdowns and financial figures

- share price and consensus valuation forecast:
Price Performance Chart heartsciences.com|HSCS - Analyst Consensus Forecast
- market capitalization information:
Market Value Heart Test Laboratories Inc.|HSCS - Enterprise Value
- shareholders' equity book value data:
Book Value per Share HeartSciences|HSCS - Company Book Value|Market Value to Book Value heartsciences.com|HSCS - Cumulative Company Assets
- debt obligations and liquidity statistics:
Aggregate Debt to Capital Heart Test Laboratories|HSCS - Long-Term Debt to Equity Ratio|Ratio of Short-Term Indebtedness to Capital Heart Test Labs|HSCS - Company Total Debt|Debt to Book Capital Heart Test Laboratories Inc.|HSCS - Company Long-Term Debts|Short-Term Debt HeartSciences|Interim Coverage Ratio heartsciences.com
- company profitability and valuation multiples indicators:
HSCS - Net Income|Future Net Profit Heart Test Laboratories|HSCS - Price to Earnings Ratio|Future Price to Earnings Multiple Heart Test Laboratories, Inc.|HSCS - Price/Earnings to Growth Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Heart Test Laboratories Inc.|HSCS - Operating profit EBITDA|Net earnings per share (EPS TTM) HeartSciences|HSCS - Net earnings per share (EPS TTM)|Year-over-year earnings per share growth for the last twelve months heartsciences.com|HSCS - Earnings per share growth in current year|Expected net earnings per share growth next year Heart Test Laboratories
- total revenue and sales volume data:
HSCS - Company Revenue|Company Future Revenue heartsciences.com|HSCS - P/S Multiple|Forward P/S Multiple Heart Test Laboratories Inc.
Summary company analytics:heartsciences.com
Brand item of Heart Test Labs

The P/S multiple determines the market value of one dollar of revenue, allowing for an assessment of sales generation efficiency relative to market capitalization without the accounting distortions of profit. By analyzing the P/S ratio chart, an investor can evaluate the resilience of Heart Test Laboratories (HSCS) to geopolitical risks affecting the logistics of components from Asia and the execution of international clinical trials for software.

Competing companies

A (agilent.com) - Market Capitalization-to-Revenue Ratio|P/S Multiple DGX (Quest Diagnostics Incorporated)|Illumina Inc (ILMN) - Price to Sales|Cologuard - P/S Multiple|RVTY - P/S Multiple|Bio-Rad Laboratories (BIO) - Price-to-Revenue Ratio|anbio.com - Market Capitalization-to-Revenue Ratio|Market Cap to Revenue SHC|QDEL (Quidel Corporation) - Market Cap to Sales Volume|Market Cap to Revenue OPK (OPKO Corp)|CDNA (CareDx Health) - Market Capitalization-to-Revenue Ratio|Maravai LifeSciences - Market Cap to Revenue|Market Cap to Sales Volume FLGT (fulgentgenetics.com)|Standard BioTools - P/S Multiple|Price to Sales Cytek Biosciences Inc|OraSure Technologies Inc (OSUR) - Price-to-Revenue Ratio|XGN - Price-to-Revenue Coefficient|Market Cap to Revenue MDXH|LUCD (luciddx.com) - Market Cap to Sales Volume|Market Cap to Revenue PRE (Prenetics Global)|IMDX (imdxinc.com) - Market Capitalization-to-Revenue Ratio|Price-to-Revenue Ratio Trinity Biotech TRIB|ProPhase Labs Corp - Price-to-Revenue Ratio|Ainos, Inc. - P/S Multiple|CODX - P/S Multiple|BMRA: P/S Multiple|CDIO (Cardio Diagnostics Holdings) - Price-to-Revenue Ratio|Price-to-Revenue Ratio Onconetix Corp|Price to Sales Virax Biolabs Corp VRAX|Price-to-Revenue Ratio Bluejay Diagnostics (BJDX)|AWH (aspirawh.com) - Market Capitalization-to-Revenue Ratio|P/S Multiple AXDX (Accelerate Diagnostics, Inc.)|P/S Multiple Centogene N.V. CNTG|ENZ: Market Cap to Revenue|Fresh2 Group Limited - Market Cap to Sales Volume|gtglabs.com (GENE) - Price-to-Revenue Ratio|Price to Sales 23andme.com (ME)|Price-to-Revenue Ratio Psychemedics Corporation